{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["medicinal plants", "natural products", "phytochemicals and solid cancer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35883653", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "28"}, "DateRevised": {"Year": "2022", "Month": "11", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "07", "Day": "15"}], "Language": ["eng"], "ELocationID": ["2209", "10.3390/cells11142209"], "Journal": {"ISSN": "2073-4409", "JournalIssue": {"Volume": "11", "Issue": "14", "PubDate": {"Year": "2022", "Month": "Jul", "Day": "15"}}, "Title": "Cells", "ISOAbbreviation": "Cells"}, "ArticleTitle": "The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer.", "Abstract": {"AbstractText": ["Natural products play a critical role in the discovery and development of numerous drugs for the treatment of various types of cancer. These phytochemicals have demonstrated anti-carcinogenic properties by interfering with the initiation, development, and progression of cancer through altering various mechanisms such as cellular proliferation, differentiation, apoptosis, angiogenesis, and metastasis. Treating multifactorial diseases, such as cancer with agents targeting a single target, might lead to limited success and, in many cases, unsatisfactory outcomes. Various epidemiological studies have shown that the steady consumption of fruits and vegetables is intensely associated with a reduced risk of cancer. Since ancient period, plants, herbs, and other natural products have been used as healing agents. Likewise, most of the medicinal ingredients accessible today are originated from the natural resources. Regardless of achievements, developing bioactive compounds and drugs from natural products has remained challenging, in part because of the problem associated with large-scale sequestration and mechanistic understanding. With significant progress in the landscape of cancer therapy and the rising use of cutting-edge technologies, we may have come to a crossroads to review approaches to identify the potential natural products and investigate their therapeutic efficacy. In the present review, we summarize the recent developments in natural products-based cancer research and its application in generating novel systemic strategies with a focus on underlying molecular mechanisms in solid cancer."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiation Oncology, School of Medicine, Washington University, Saint Louis, MO 63130, USA."}], "LastName": "Muhammad", "ForeName": "Naoshad", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "G-Bioscience, 9800 Page Ave., St. Louis, MO 63132, USA."}], "LastName": "Usmani", "ForeName": "Darksha", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Child Health, University of Missouri, Columbia, MO 65211, USA."}], "LastName": "Tarique", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Missouri, Columbia, MO 65211, USA."}], "LastName": "Naz", "ForeName": "Huma", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Bundelkhand University Jhansi, Jhansi 284128, Uttar Pradesh, India."}], "LastName": "Ashraf", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "IFFCO Nano Biotechnology Research Center, Kalol 382423, Gujarat, India."}], "LastName": "Raliya", "ForeName": "Ramesh", "Initials": "R"}, {"Identifier": ["0000-0003-4550-415X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Tabrez", "ForeName": "Shams", "Initials": "S"}, {"Identifier": ["0000-0002-2855-5134"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Zughaibi", "ForeName": "Torki A", "Initials": "TA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Alsaieedi", "ForeName": "Ahdab", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, College of Science, University of Jeddah, Jeddah 21959, Saudi Arabia."}], "LastName": "Hakeem", "ForeName": "Israa J", "Initials": "IJ"}, {"Identifier": ["0000-0002-1641-4633"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Suhail", "ForeName": "Mohd", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cells", "NlmUniqueID": "101600052", "ISSNLinking": "2073-4409"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Immunotherapy"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neovascularization, Pathologic"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Phytochemicals"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "World Health Organization . International Agency for Research on Cancer. World Health Organization; Geneva, Switzerland: 2019."}, {"Citation": "Nagai H., Kim Y.H. Cancer prevention from the perspective of global cancer burden patterns. J. Thorac. Dis. 2017;9:448\u2013451. doi: 10.21037/jtd.2017.02.75.", "ArticleIdList": ["10.21037/jtd.2017.02.75", "PMC5394024", "28449441"]}, {"Citation": "Cho W.C. Molecular Connections of Aging and Cancer. Aging Dis. 2017;8:685\u2013687. doi: 10.14336/AD.2017.0822.", "ArticleIdList": ["10.14336/AD.2017.0822", "PMC5614330", "28966810"]}, {"Citation": "Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., et al. A review of human carcinogens--Part B: Biological agents. Lancet Oncol. 2009;10:321\u2013322. doi: 10.1016/S1470-2045(09)70096-8.", "ArticleIdList": ["10.1016/S1470-2045(09)70096-8", "19350698"]}, {"Citation": "Lombard D.B., Chua K.F., Mostoslavsky R., Franco S., Gostissa M., Alt F.W. DNA repair, genome stability, and aging. Cell. 2005;120:497\u2013512. doi: 10.1016/j.cell.2005.01.028.", "ArticleIdList": ["10.1016/j.cell.2005.01.028", "15734682"]}, {"Citation": "Sharifi-Rad J., Quispe C., Patra J.K., Singh Y.D., Panda M.K., Das G., Adetunji C.O., Michael O.S., Sytar O., Polito L., et al. Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy. Oxid. Med. Cell. Longev. 2021;2021:3687700. doi: 10.1155/2021/3687700.", "ArticleIdList": ["10.1155/2021/3687700", "PMC8545549", "34707776"]}, {"Citation": "Docea A.O., Mitru\u0163 P., Grigore D., Pirici D., C\u0103lina D.C., Gofi\u0163\u0103 E. Immunohistochemical expression of TGF beta (TGF-\u03b2), TGF beta receptor 1 (TGFBR1), and Ki67 in intestinal variant of gastric adenocarcinomas. Rom. J. Morphol. Embryol. 2012;53((Suppl. S3)):683\u2013692.", "ArticleIdList": ["23188426"]}, {"Citation": "Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646\u2013674. doi: 10.1016/j.cell.2011.02.013.", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Housman G., Byler S., Heerboth S., Lapinska K., Longacre M., Snyder N., Sarkar S. Drug resistance in cancer: An overview. Cancers. 2014;6:1769\u20131792. doi: 10.3390/cancers6031769.", "ArticleIdList": ["10.3390/cancers6031769", "PMC4190567", "25198391"]}, {"Citation": "International Human Genome Sequencing Consortium Finishing the euchromatic sequence of the human genome. Nature. 2004;431:931\u2013945. doi: 10.1038/nature03001.", "ArticleIdList": ["10.1038/nature03001", "15496913"]}, {"Citation": "The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium Pan-cancer analysis of whole genomes. Nature. 2020;578:82\u201393. doi: 10.1038/s41586-020-1969-6.", "ArticleIdList": ["10.1038/s41586-020-1969-6", "PMC7025898", "32025007"]}, {"Citation": "Li L., Zhao G.-D., Shi Z., Qi L.-L., Zhou L.-Y., Fu Z.-X. The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC. Oncol. Lett. 2016;12:3045\u20133050. doi: 10.3892/ol.2016.5110.", "ArticleIdList": ["10.3892/ol.2016.5110", "PMC5103898", "27899961"]}, {"Citation": "Farooq M., Khan A.W., Kim M.S., Choi S. The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration. Cells. 2021;10:3242. doi: 10.3390/cells10113242.", "ArticleIdList": ["10.3390/cells10113242", "PMC8622657", "34831463"]}, {"Citation": "Mendoza M.C., Er E.E., Blenis J. The Ras-ERK and PI3K-mTOR pathways: Cross-talk and compensation. Trends Biochem Sci. 2011;36:320\u2013328. doi: 10.1016/j.tibs.2011.03.006.", "ArticleIdList": ["10.1016/j.tibs.2011.03.006", "PMC3112285", "21531565"]}, {"Citation": "Alharthy S.A., Tabrez S., Mirza A.A., Zughaibi T.A., Firoz C.K., Dutta M. Sugiol Suppresses the Proliferation of Human U87 Glioma Cells via Induction of Apoptosis and Cell Cycle Arrest. Evid. Based Complement. Altern. Med. 2022;2022:7658899. doi: 10.1155/2022/7658899.", "ArticleIdList": ["10.1155/2022/7658899", "PMC9168084", "35677372"]}, {"Citation": "Zughaibi T.A., Suhail M., Tarique M., Tabrez S. Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach. Int. J. Mol. Sci. 2021;22:12455. doi: 10.3390/ijms222212455.", "ArticleIdList": ["10.3390/ijms222212455", "PMC8621356", "34830339"]}, {"Citation": "Badar Ul Islam n., Khan M.S., Husain F.M., Rehman M.T., Zughaibi T.A., Abuzenadah A.M., Urooj M., Kamal M.A., Tabrez S. mTOR Targeted Cancer Chemoprevention by Flavonoids. Curr. Med. Chem. 2021;28:8068\u20138082. doi: 10.2174/0929867327666201109122025.", "ArticleIdList": ["10.2174/0929867327666201109122025", "33167824"]}, {"Citation": "Islam B., Suhail M., Khan M., Ahmad A., Zughaibi T., Husain F., Rehman M.T., Tabrez S. Flavonoids and PI3K/Akt/mTOR signaling cascade: A potential crosstalk in anticancer treatment. Curr. Med. Chem. 2021;28:8083\u20138097. doi: 10.2174/0929867328666210804091548.", "ArticleIdList": ["10.2174/0929867328666210804091548", "34348607"]}, {"Citation": "Najmi A., Javed S.A., Al Bratty M., Alhazmi H.A. Modern Approaches in the Discovery and Development of Plant-Based Natural Products and Their Analogues as Potential Therapeutic Agents. Molecules. 2022;27:349. doi: 10.3390/molecules27020349.", "ArticleIdList": ["10.3390/molecules27020349", "PMC8779633", "35056662"]}, {"Citation": "Islam B.U., Suhail M., Khan M.K., Zughaibi T.A., Alserihi R.F., Zaidi S.K., Tabrez S. Polyphenols as anticancer agents: Toxicological concern to healthy cells. Phytother. Res. 2021;35:6063\u20136079. doi: 10.1002/ptr.7216.", "ArticleIdList": ["10.1002/ptr.7216", "34679214"]}, {"Citation": "Veeresham C. Natural products derived from plants as a source of drugs. J. Adv. Pharm. Technol. Res. 2012;3:200\u2013201. doi: 10.4103/2231-4040.104709.", "ArticleIdList": ["10.4103/2231-4040.104709", "PMC3560124", "23378939"]}, {"Citation": "Bracke M.E., Vanhoecke B.W.A., Derycke L., Bolca S., Possemiers S., Heyerick A., Stevens C.V., De Keukeleire D., Depypere H.T., Verstraete W., et al. Plant polyphenolics as anti-invasive cancer agents. Anti-cancer. Agents Med. Chem. 2008;8:171\u2013185. doi: 10.2174/187152008783497037.", "ArticleIdList": ["10.2174/187152008783497037", "18288920"]}, {"Citation": "Singh S., Sharma B., Kanwar S.S., Kumar A. Lead Phytochemicals for Anticancer Drug Development. Front Plant Sci. 2016;7:1667. doi: 10.3389/fpls.2016.01667.", "ArticleIdList": ["10.3389/fpls.2016.01667", "PMC5099879", "27877185"]}, {"Citation": "Sultana S., Munir N., Mahmood Z., Riaz M., Akram M., Rebezov M., Kuderinova N., Moldabayeva Z., Shariati M.A., Rauf A., et al. Molecular targets for the management of cancer using Curcuma longa Linn. phytoconstituents: A Review. Biomed. Pharmacother. 2021;135:111078. doi: 10.1016/j.biopha.2020.111078.", "ArticleIdList": ["10.1016/j.biopha.2020.111078", "33433356"]}, {"Citation": "Tomeh M.A., Hadianamrei R., Zhao X. A Review of Curcumin and Its Derivatives as Anticancer Agents. Int. J. Mol. Sci. 2019;20:1033. doi: 10.3390/ijms20051033.", "ArticleIdList": ["10.3390/ijms20051033", "PMC6429287", "30818786"]}, {"Citation": "Hoda N., Naz H., Jameel E., Shandilya A., Dey S., Hassan M.I., Ahmad F., Jayaram B. Curcumin specifically binds to the human calcium\u2013calmodulin-dependent protein kinase IV: Fluorescence and molecular dynamics simulation studies. J. Biomol. Struct. Dyn. 2016;34:572\u2013584. doi: 10.1080/07391102.2015.1046934.", "ArticleIdList": ["10.1080/07391102.2015.1046934", "25929263"]}, {"Citation": "Mengie Ayele T., Tilahun Muche Z., Behaile Teklemariam A., Bogale Kassie A., Chekol Abebe E. Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review. J. Inflamm. Res. 2022;15:1349\u20131364. doi: 10.2147/JIR.S353489.", "ArticleIdList": ["10.2147/JIR.S353489", "PMC8887966", "35241923"]}, {"Citation": "Sun Y., Liu L., Wang Y., He A., Hu H., Zhang J., Han M., Huang Y. Curcumin inhibits the proliferation and invasion of MG-63 cells through inactivation of the p-JAK2/p-STAT3 pathway. Oncol. Targets Ther. 2019;12:2011\u20132021. doi: 10.2147/OTT.S172909.", "ArticleIdList": ["10.2147/OTT.S172909", "PMC6421868", "30936718"]}, {"Citation": "Zhou Y., Sun Y., Hou W., Ma L., Tao Y., Li D., Xu C., Bao J., Fan W. The JAK2/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro. Int. J. Mol. Med. 2020;46:191\u2013200. doi: 10.3892/ijmm.2020.4592.", "ArticleIdList": ["10.3892/ijmm.2020.4592", "PMC7255460", "32377718"]}, {"Citation": "Pagliuca A., Valvo C., Fabrizi E., di Martino S., Biffoni M., Runci D., Forte S., De Maria R., Ricci-Vitiani L. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene. 2013;32:4806\u20134813. doi: 10.1038/onc.2012.495.", "ArticleIdList": ["10.1038/onc.2012.495", "23128394"]}, {"Citation": "Liu Y., Sun H., Makabel B., Cui Q., Li J., Su C., Ashby Jr C.R., Chen Z., Zhang J. The targeting of non-coding RNAs by curcumin: Facts and hopes for cancer therapy (Review) Oncol. Rep. 2019;42:20\u201334. doi: 10.3892/or.2019.7148.", "ArticleIdList": ["10.3892/or.2019.7148", "PMC6549103", "31059075"]}, {"Citation": "Zhang Y., Yu X., Chen L., Zhang Z., Feng S. EZH2 overexpression is associated with poor prognosis in patients with glioma. Oncotarget. 2016;8:565\u2013573. doi: 10.18632/oncotarget.13478.", "ArticleIdList": ["10.18632/oncotarget.13478", "PMC5352178", "27880940"]}, {"Citation": "Hashem S., Ali T.A., Akhtar S., Nisar S., Sageena G., Ali S., Al-Mannai S., Therachiyil L., Mir R., Elfaki I., et al. Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents. Biomed. Pharmacother. 2022;150:113054. doi: 10.1016/j.biopha.2022.113054.", "ArticleIdList": ["10.1016/j.biopha.2022.113054", "35658225"]}, {"Citation": "Adiwidjaja J., McLachlan A.J., Boddy A.V. Curcumin as a clinically-promising anti-cancer agent: Pharmacokinetics and drug interactions. Expert Opin. Drug Metab. Toxicol. 2017;13:953\u2013972. doi: 10.1080/17425255.2017.1360279.", "ArticleIdList": ["10.1080/17425255.2017.1360279", "28776444"]}, {"Citation": "Wu L., Guo L., Liang Y., Liu X., Jiang L., Wang L. Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway. Oncol. Rep. 2015;34:3311\u20133317. doi: 10.3892/or.2015.4279.", "ArticleIdList": ["10.3892/or.2015.4279", "26397387"]}, {"Citation": "Katz E., Nisani S., Chamovitz D.A. Indole-3-carbinol: A plant hormone combatting cancer. F1000Res. 2018;7:F1000-Faculty Rev-689. doi: 10.12688/f1000research.14127.1.", "ArticleIdList": ["10.12688/f1000research.14127.1", "PMC5989150", "29904587"]}, {"Citation": "Marconett C.N., Singhal A.K., Sundar S.N., Firestone G.L. Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells. Mol. Cell Endocrinol. 2012;363:74\u201384. doi: 10.1016/j.mce.2012.07.008.", "ArticleIdList": ["10.1016/j.mce.2012.07.008", "PMC3684449", "22835548"]}, {"Citation": "Lim H.M., Park S.-H., Nam M.J. Induction of apoptosis in indole-3-carbinol-treated lung cancer H1299 cells via ROS level elevation. Hum. Exp. Toxicol. 2021;40:812\u2013825. doi: 10.1177/0960327120969968.", "ArticleIdList": ["10.1177/0960327120969968", "33118390"]}, {"Citation": "Tin A.S., Park A.H., Sundar S.N., Firestone G.L. Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells. BMC Biol. 2014;12:72. doi: 10.1186/s12915-014-0072-6.", "ArticleIdList": ["10.1186/s12915-014-0072-6", "PMC4180847", "25209720"]}, {"Citation": "Suhail M., Mohammad T., Naoshad M., Huma N., Abdul H., Torki A.Z., Mohammad A.K., Mohd R. A Critical Transcription Factor NF-\u03baB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options. Curr. Med. Chem. 2021;28:4117\u20134132. doi: 10.2174/0929867327666201111142307.", "ArticleIdList": ["10.2174/0929867327666201111142307", "33176636"]}, {"Citation": "Fadlalla K., Elgendy R., Gilbreath E., Pondugula S.R., Yehualaeshet T., Mansour M., Serbessa T., Manne U., Samuel T. 3-(2-Bromoethyl)-indole inhibits the growth of cancer cells and NF-\u03baB activation. Oncol. Rep. 2015;34:495\u2013503. doi: 10.3892/or.2015.3970.", "ArticleIdList": ["10.3892/or.2015.3970", "PMC4484612", "26063116"]}, {"Citation": "Hong C., Kim H.A., Firestone G.L., Bjeldanes L.F. 3,3\u2032-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21WAF1/CIP1 expression. Carcinogenesis. 2002;23:1297\u20131305. doi: 10.1093/carcin/23.8.1297.", "ArticleIdList": ["10.1093/carcin/23.8.1297", "12151347"]}, {"Citation": "Vivar O.I., Lin C.-L., Firestone G.L., Bjeldanes L.F. 3,3\u2032-Diindolylmethane Induces a G1 Arrest in Human Prostate Cancer Cells Irrespective of Androgen Receptor and p53 Status. Biochem. Pharmacol. 2009;78:469\u2013476. doi: 10.1016/j.bcp.2009.05.008.", "ArticleIdList": ["10.1016/j.bcp.2009.05.008", "PMC2706920", "19433067"]}, {"Citation": "Mart\u00edn-Ruiz A., Pe\u00f1a L., Gonz\u00e1lez-Gil A., D\u00edez-C\u00f3rdova L.T., C\u00e1ceres S., Illera J.C. Effects of indole-3-carbinol on steroid hormone profile and tumor progression in a mice model of canine inflammatory mammarycancer. BMC Cancer. 2018;18:626. doi: 10.1186/s12885-018-4518-z.", "ArticleIdList": ["10.1186/s12885-018-4518-z", "PMC5987405", "29866056"]}, {"Citation": "Lee C.M., Lee J., Nam M.J., Park S.-H. Indole-3-Carbinol Induces Apoptosis in Human Osteosarcoma MG-63 and U2OS Cells. Biomed. Res. Int. 2018;2018:e7970618. doi: 10.1155/2018/7970618.", "ArticleIdList": ["10.1155/2018/7970618", "PMC6304504", "30627573"]}, {"Citation": "Chedea V.S., Vica\u015f S.I., Sticozzi C., Pessina F., Frosini M., Maioli E., Valacchi G. Resveratrol: From diet to topical usage. Food Funct. 2017;8:3879\u20133892. doi: 10.1039/C7FO01086A.", "ArticleIdList": ["10.1039/C7FO01086A", "29034918"]}, {"Citation": "Nawaz W., Zhou Z., Deng S., Ma X., Ma X., Li C., Shu X. Therapeutic Versatility of Resveratrol Derivatives. Nutrients. 2017;9:1188. doi: 10.3390/nu9111188.", "ArticleIdList": ["10.3390/nu9111188", "PMC5707660", "29109374"]}, {"Citation": "Zhao Y., Tang H., Zeng X., Ye D., Liu J. Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells. Biomed. Pharmacother. 2018;98:36\u201344. doi: 10.1016/j.biopha.2017.12.029.", "ArticleIdList": ["10.1016/j.biopha.2017.12.029", "29241073"]}, {"Citation": "Liu Z., Li Y., Yang R. Effects of resveratrol on vascular endothelial growth factor expression in osteosarcoma cells and cell proliferation. Oncol. Lett. 2012;4:837\u2013839. doi: 10.3892/ol.2012.824.", "ArticleIdList": ["10.3892/ol.2012.824", "PMC3506664", "23205110"]}, {"Citation": "Rauf A., Imran M., Butt M.S., Nadeem M., Peters D.G., Mubarak M.S. Resveratrol as an anti-cancer agent: A review. Crit. Rev. Food Sci. Nutr. 2018;58:1428\u20131447. doi: 10.1080/10408398.2016.1263597.", "ArticleIdList": ["10.1080/10408398.2016.1263597", "28001084"]}, {"Citation": "Imran M., Salehi B., Sharifi-Rad J., Aslam Gondal T., Saeed F., Imran A., Shahbaz M., Tsouh Fokou P.V., Umair Arshad M., Khan H., et al. Kaempferol: A Key Emphasis to Its Anticancer Potential. Molecules. 2019;24:2277. doi: 10.3390/molecules24122277.", "ArticleIdList": ["10.3390/molecules24122277", "PMC6631472", "31248102"]}, {"Citation": "Sharifi-Rad M., Fokou P.V.T., Sharopov F., Martorell M., Ademiluyi A.O., Rajkovic J., Salehi B., Martins N., Iriti M., Sharifi-Rad J. Antiulcer Agents: From Plant Extracts to Phytochemicals in Healing Promotion. Molecules. 2018;23:1751. doi: 10.3390/molecules23071751.", "ArticleIdList": ["10.3390/molecules23071751", "PMC6100067", "30018251"]}, {"Citation": "Kashyap D., Sharma A., Tuli H.S., Sak K., Punia S., Mukherjee T.K. Kaempferol\u2014A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements. J. Funct. Foods. 2017;30:203\u2013219. doi: 10.1016/j.jff.2017.01.022.", "ArticleIdList": ["10.1016/j.jff.2017.01.022", "PMC7104980", "32288791"]}, {"Citation": "Riahi-Chebbi I., Souid S., Othman H., Haoues M., Karoui H., Morel A., Srairi-Abid N., Essafi M., Essafi-Benkhadir K. The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells. Sci. Rep. 2019;9:195. doi: 10.1038/s41598-018-36808-z.", "ArticleIdList": ["10.1038/s41598-018-36808-z", "PMC6336835", "30655588"]}, {"Citation": "Choi J.-B., Kim J.-H., Lee H., Pak J.-N., Shim B.S., Kim S.-H. Reactive Oxygen Species and p53 Mediated Activation of p38 and Caspases is Critically Involved in Kaempferol Induced Apoptosis in Colorectal Cancer Cells. J. Agric. Food Chem. 2018;66:9960\u20139967. doi: 10.1021/acs.jafc.8b02656.", "ArticleIdList": ["10.1021/acs.jafc.8b02656", "30211553"]}, {"Citation": "Lee H.S., Cho H.J., Yu R., Lee K.W., Chun H.S., Park J.H.Y. Mechanisms Underlying Apoptosis-Inducing Effects of Kaempferol in HT-29 Human Colon Cancer Cells. Int. J. Mol. Sci. 2014;15:2722\u20132737. doi: 10.3390/ijms15022722.", "ArticleIdList": ["10.3390/ijms15022722", "PMC3958878", "24549175"]}, {"Citation": "Yoshida T., Konishi M., Horinaka M., Yasuda T., Goda A.E., Taniguchi H., Yano K., Wakada M., Sakai T. Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem. Biophys. Res. Commun. 2008;375:129\u2013133. doi: 10.1016/j.bbrc.2008.07.131.", "ArticleIdList": ["10.1016/j.bbrc.2008.07.131", "18680719"]}, {"Citation": "Kim S.-H., Hwang K.-A., Choi K.-C. Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models. J. Nutr. Biochem. 2016;28:70\u201382. doi: 10.1016/j.jnutbio.2015.09.027.", "ArticleIdList": ["10.1016/j.jnutbio.2015.09.027", "26878784"]}, {"Citation": "Tabrez S., Hoque M., Suhail M., Khan M.I., Zughaibi T.A., Khan A.U. Identification of anticancer bioactive compounds derived from Ficus sp. by targeting Poly[ADP-ribose]polymerase 1 (PARP-1) J. King Saud Univ.-Sci. 2022;34:102079. doi: 10.1016/j.jksus.2022.102079.", "ArticleIdList": ["10.1016/j.jksus.2022.102079"]}, {"Citation": "Li C., Zhao Y., Yang D., Yu Y., Guo H., Zhao Z., Zhang B., Yin X. Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Biochem. Cell Biol. 2015;93:16\u201327. doi: 10.1139/bcb-2014-0067.", "ArticleIdList": ["10.1139/bcb-2014-0067", "25453494"]}, {"Citation": "Suhail M., Parveen A., Husain A., Rehan M. Exploring Inhibitory Mechanisms of Green Tea Catechins as Inhibitors of a Cancer Therapeutic Target, Nuclear Factor-\u03baB (NF-\u03baB) Biosci. Biotechnol. Res. Asia. 2019;16:715\u2013723. doi: 10.13005/bbra/2787.", "ArticleIdList": ["10.13005/bbra/2787"]}, {"Citation": "Reygaert W.C. Green Tea Catechins: Their Use in Treating and Preventing Infectious Diseases. Biomed. Res. Int. 2018;2018:9105261. doi: 10.1155/2018/9105261.", "ArticleIdList": ["10.1155/2018/9105261", "PMC6076941", "30105263"]}, {"Citation": "Sanna V., Singh C.K., Jashari R., Adhami V.M., Chamcheu J.C., Rady I., Sechi M., Mukhtar H., Siddiqui I.A. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Sci. Rep. 2017;7:41573. doi: 10.1038/srep41573.", "ArticleIdList": ["10.1038/srep41573", "PMC5286400", "28145499"]}, {"Citation": "Naponelli V., Ramazzina I., Lenzi C., Bettuzzi S., Rizzi F. Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges. Antioxidants. 2017;6:26. doi: 10.3390/antiox6020026.", "ArticleIdList": ["10.3390/antiox6020026", "PMC5488006", "28379200"]}, {"Citation": "Lin R.-W., Chen C.-H., Wang Y.-H., Ho M.-L., Hung S.-H., Chen I.-S., Wang G.-J. (\u2212)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB. Biochem. Biophys. Res. Commun. 2009;379:1033\u20131037. doi: 10.1016/j.bbrc.2009.01.007.", "ArticleIdList": ["10.1016/j.bbrc.2009.01.007", "19150340"]}, {"Citation": "Johnson J.J., Bailey H.H., Mukhtar H. Green tea polyphenols for prostate cancer chemoprevention: A translational perspective. Phytomedicine. 2010;17:3\u201313. doi: 10.1016/j.phymed.2009.09.011.", "ArticleIdList": ["10.1016/j.phymed.2009.09.011", "PMC2789276", "19959000"]}, {"Citation": "Wei R., Wirkus J., Yang Z., Machuca J., Esparza Y., Mackenzie G.G. EGCG sensitizes chemotherapeutic-induced cytotoxicity by targeting the ERK pathway in multiple cancer cell lines. Arch. Biochem. Biophys. 2020;692:108546. doi: 10.1016/j.abb.2020.108546.", "ArticleIdList": ["10.1016/j.abb.2020.108546", "PMC7494570", "32818507"]}, {"Citation": "Shirakami Y., Shimizu M. Possible Mechanisms of Green Tea and Its Constituents against Cancer. Molecules. 2018;23:2284. doi: 10.3390/molecules23092284.", "ArticleIdList": ["10.3390/molecules23092284", "PMC6225266", "30205425"]}, {"Citation": "Chen B.-H., Hsieh C.-H., Tsai S.-Y., Wang C.-Y., Wang C.-C. Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway. Sci. Rep. 2020;10:5163. doi: 10.1038/s41598-020-62136-2.", "ArticleIdList": ["10.1038/s41598-020-62136-2", "PMC7083948", "32198390"]}, {"Citation": "Belobrov S., Seers C., Reynolds E., Cirillo N., McCullough M. Functional and molecular effects of a green tea constituent on oral cancer cells. J. Oral. Pathol. Med. 2019;48:604\u2013610. doi: 10.1111/jop.12914.", "ArticleIdList": ["10.1111/jop.12914", "31188490"]}, {"Citation": "Alserihi R.F., Mohammed M.R.S., Kaleem M., Khan M.I., Sechi M., Sanna V., Zughaibi T.A., Abuzenadah A.M., Tabrez S. Development of (\u2212)-epigallocatechin-3-gallate-loaded folate receptor-targeted nanoparticles for prostate cancer treatment. Nanotechnol. Rev. 2022;11:298\u2013311. doi: 10.1515/ntrev-2022-0013.", "ArticleIdList": ["10.1515/ntrev-2022-0013"]}, {"Citation": "Bharrhan S., Koul A., Chopra K., Rishi P. Catechin Suppresses an Array of Signalling Molecules and Modulates Alcohol-Induced Endotoxin Mediated Liver Injury in a Rat Model. PLoS ONE. 2011;6:e20635. doi: 10.1371/journal.pone.0020635.", "ArticleIdList": ["10.1371/journal.pone.0020635", "PMC3108820", "21673994"]}, {"Citation": "Tang G., Xu Y., Zhang C., Wang N., Li H., Feng Y. Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism. Antioxidants. 2021;10:1076. doi: 10.3390/antiox10071076.", "ArticleIdList": ["10.3390/antiox10071076", "PMC8301033", "34356308"]}, {"Citation": "Calgarotto A.K., Longhini A.L., Pericole de Souza F.V., Duarte A.S.S., Ferro K.P., Santos I., Maso V., Olalla Saad S.T., Torello C.O. Immunomodulatory Effect of Green Tea Treatment in Combination with Low-dose Chemotherapy in Elderly Acute Myeloid Leukemia Patients with Myelodysplasia-related Changes. Integr. Cancer Ther. 2021;20:15347354211002647. doi: 10.1177/15347354211002647.", "ArticleIdList": ["10.1177/15347354211002647", "PMC7995304", "33754891"]}, {"Citation": "Huang A.-C., Cheng H.-Y., Lin T.-S., Chen W.-H., Lin J.-H., Lin J.-J., Lu C.-C., Chiang J.-H., Hsu S.-C., Wu P.-P., et al. Epigallocatechin gallate (EGCG), influences a murine WEHI-3 leukemia model in vivo through enhancing phagocytosis of macrophages and populations of T- and B-cells. In Vivo. 2013;27:627\u2013634.", "ArticleIdList": ["23988898"]}, {"Citation": "Tuli H.S., Tuorkey M.J., Thakral F., Sak K., Kumar M., Sharma A.K., Sharma U., Jain A., Aggarwal V., Bishayee A. Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances. Front. Pharmacol. 2019;10:1336. doi: 10.3389/fphar.2019.01336.", "ArticleIdList": ["10.3389/fphar.2019.01336", "PMC6910185", "31866857"]}, {"Citation": "Goh Y.X., Jalil J., Lam K.W., Husain K., Premakumar C.M. Genistein: A Review on its Anti-Inflammatory Properties. Front. Pharmacol. 2022;13:820969. doi: 10.3389/fphar.2022.820969.", "ArticleIdList": ["10.3389/fphar.2022.820969", "PMC8818956", "35140617"]}, {"Citation": "Irrera N., Pizzino G., D\u2019Anna R., Vaccaro M., Arcoraci V., Squadrito F., Altavilla D., Bitto A. Dietary Management of Skin Health: The Role of Genistein. Nutrients. 2017;9:622. doi: 10.3390/nu9060622.", "ArticleIdList": ["10.3390/nu9060622", "PMC5490601", "28629129"]}, {"Citation": "Qi W., Weber C.R., Wasland K., Savkovic S.D. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer. 2011;11:219. doi: 10.1186/1471-2407-11-219.", "ArticleIdList": ["10.1186/1471-2407-11-219", "PMC3134425", "21639915"]}, {"Citation": "Deldar Abad Paskeh M., Asadi S., Zabolian A., Saleki H., Khoshbakht M.A., Sabet S., Naghdi M.J., Hashemi M., Hushmandi K., Ashrafizadeh M., et al. Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies. Int. J. Mol. Sci. 2021;22:11669. doi: 10.3390/ijms222111669.", "ArticleIdList": ["10.3390/ijms222111669", "PMC8584029", "34769099"]}, {"Citation": "Park S., Kim H., Kim K., Roh S. Sonic hedgehog signalling regulates the self-renewal and proliferation of skin-derived precursor cells in mice. Cell Prolif. 2018;51:e12500. doi: 10.1111/cpr.12500.", "ArticleIdList": ["10.1111/cpr.12500", "PMC6528853", "30151845"]}, {"Citation": "Javed Z., Khan K., Herrera-Bravo J., Naeem S., Iqbal M.J., Sadia H., Qadri Q.R., Raza S., Irshad A., Akbar A., et al. Genistein as a regulator of signaling pathways and microRNAs in different types of cancers. Cancer Cell Int. 2021;21:388. doi: 10.1186/s12935-021-02091-8.", "ArticleIdList": ["10.1186/s12935-021-02091-8", "PMC8296701", "34289845"]}, {"Citation": "Hsieh P.-L., Liao Y.-W., Hsieh C.-W., Chen P.-N., Yu C.-C. Soy Isoflavone Genistein Impedes Cancer Stemness and Mesenchymal Transition in Head and Neck Cancer through Activating miR-34a/RTCB Axis. Nutrients. 2020;12:1924. doi: 10.3390/nu12071924.", "ArticleIdList": ["10.3390/nu12071924", "PMC7400540", "32610494"]}, {"Citation": "Dehelean C.A., Marcovici I., Soica C., Mioc M., Coricovac D., Iurciuc S., Cretu O.M., Pinzaru I. Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. Molecules. 2021;26:1109. doi: 10.3390/molecules26041109.", "ArticleIdList": ["10.3390/molecules26041109", "PMC7922180", "33669817"]}, {"Citation": "Pons-Tostivint E., Thibault B., Guillermet-Guibert J. Targeting PI3K Signaling in Combination Cancer Therapy. Trends Cancer. 2017;3:454\u2013469. doi: 10.1016/j.trecan.2017.04.002.", "ArticleIdList": ["10.1016/j.trecan.2017.04.002", "28718419"]}, {"Citation": "van Krieken J.H.J.M., Jung A., Kirchner T., Carneiro F., Seruca R., Bosman F.T., Quirke P., Fl\u00e9jou J.F., Plato Hansen T., de Hertogh G., et al. KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: Proposal for an European quality assurance program. Virchows Arch. 2008;453:417\u2013431. doi: 10.1007/s00428-008-0665-y.", "ArticleIdList": ["10.1007/s00428-008-0665-y", "18802721"]}, {"Citation": "Rastogi C., Rajanna S., Puri N. Current Molecularly Targeted Therapies against EGFR for Cancer. J. Cancer Sci. 2013;6:e131. doi: 10.4172/1948-5956.1000e131.", "ArticleIdList": ["10.4172/1948-5956.1000e131"]}, {"Citation": "Zhang J., Yang P.L., Gray N.S. Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer. 2009;9:28\u201339. doi: 10.1038/nrc2559.", "ArticleIdList": ["10.1038/nrc2559", "19104514"]}, {"Citation": "Hojjat-Farsangi M. Small-molecule inhibitors of the receptor tyrosine kinases: Promising tools for targeted cancer therapies. Int. J. Mol. Sci. 2014;15:13768\u201313801. doi: 10.3390/ijms150813768.", "ArticleIdList": ["10.3390/ijms150813768", "PMC4159824", "25110867"]}, {"Citation": "Zeng L., Tang M., Pi C., Zheng J., Gao S., Chabanne T., Chauvin R., Cheng W., Lin H., Xu R., et al. Novel Ferrocene Derivatives Induce Apoptosis through Mitochondria-Dependent and Cell Cycle Arrest via PI3K/Akt/mTOR Signaling Pathway in T Cell Acute Lymphoblastic Leukemia. Cancers. 2021;13:4677. doi: 10.3390/cancers13184677.", "ArticleIdList": ["10.3390/cancers13184677", "PMC8467123", "34572904"]}, {"Citation": "Huang T.-T., Lampert E.J., Coots C., Lee J.-M. Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer. Cancer Treat. Rev. 2020;86:102021. doi: 10.1016/j.ctrv.2020.102021.", "ArticleIdList": ["10.1016/j.ctrv.2020.102021", "PMC7272282", "32311593"]}, {"Citation": "Owusu-Brackett N., Shariati M., Meric-Bernstam F. Role of PI3K/AKT/mTOR in Cancer Signaling. In: Badve S., Kumar G.L., editors. Predictive Biomarkers in Oncology: Applications in Precision Medicine. Springer International Publishing; Cham, Switzerland: 2019. pp. 263\u2013270."}, {"Citation": "Popova N.V., J\u00fccker M. The Role of mTOR Signaling as a Therapeutic Target in Cancer. Int. J. Mol. Sci. 2021;22:1743. doi: 10.3390/ijms22041743.", "ArticleIdList": ["10.3390/ijms22041743", "PMC7916160", "33572326"]}, {"Citation": "Miricescu D., Totan A., Stanescu-Spinu I.-I., Badoiu S.C., Stefani C., Greabu M. PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects. Int. J. Mol. Sci. 2020;22:173. doi: 10.3390/ijms22010173.", "ArticleIdList": ["10.3390/ijms22010173", "PMC7796017", "33375317"]}, {"Citation": "Yang J., Nie J., Ma X., Wei Y., Peng Y., Wei X. Targeting PI3K in cancer: Mechanisms and advances in clinical trials. Mol. Cancer. 2019;18:26. doi: 10.1186/s12943-019-0954-x.", "ArticleIdList": ["10.1186/s12943-019-0954-x", "PMC6379961", "30782187"]}, {"Citation": "Mandal K. Review of PIP2 in Cellular Signaling, Functions and Diseases. Int. J. Mol. Sci. 2020;21:8342. doi: 10.3390/ijms21218342.", "ArticleIdList": ["10.3390/ijms21218342", "PMC7664428", "33172190"]}, {"Citation": "Toker A., Marmiroli S. Signaling specificity in the Akt pathway in biology and disease. Adv. Biol. Regul. 2014;55:28\u201338. doi: 10.1016/j.jbior.2014.04.001.", "ArticleIdList": ["10.1016/j.jbior.2014.04.001", "PMC4062840", "24794538"]}, {"Citation": "Truebestein L., Hornegger H., Anrather D., Hartl M., Fleming K.D., Stariha J.T.B., Pardon E., Steyaert J., Burke J.E., Leonard T.A. Structure of autoinhibited Akt1 reveals mechanism of PIP3-mediated activation. Proc. Natl. Acad. Sci. USA. 2021;118:e2101496118. doi: 10.1073/pnas.2101496118.", "ArticleIdList": ["10.1073/pnas.2101496118", "PMC8379990", "34385319"]}, {"Citation": "Manning B.D., Toker A. AKT/PKB Signaling: Navigating the Network. Cell. 2017;169:381\u2013405. doi: 10.1016/j.cell.2017.04.001.", "ArticleIdList": ["10.1016/j.cell.2017.04.001", "PMC5546324", "28431241"]}, {"Citation": "Manning B.D., Cantley L.C. Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 2003;28:573\u2013576. doi: 10.1016/j.tibs.2003.09.003.", "ArticleIdList": ["10.1016/j.tibs.2003.09.003", "14607085"]}, {"Citation": "Ballesteros-\u00c1lvarez J., Andersen J.K. mTORC2: The other mTOR in autophagy regulation. Aging Cell. 2021;20:e13431. doi: 10.1111/acel.13431.", "ArticleIdList": ["10.1111/acel.13431", "PMC8373318", "34250734"]}, {"Citation": "Yuan J., Dong X., Yap J., Hu J. The MAPK and AMPK signalings: Interplay and implication in targeted cancer therapy. J. Hematol. Oncol. 2020;13:113. doi: 10.1186/s13045-020-00949-4.", "ArticleIdList": ["10.1186/s13045-020-00949-4", "PMC7433213", "32807225"]}, {"Citation": "Santarpia L., Lippman S.M., El-Naggar A.K. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin. Ther. Targets. 2012;16:103\u2013119. doi: 10.1517/14728222.2011.645805.", "ArticleIdList": ["10.1517/14728222.2011.645805", "PMC3457779", "22239440"]}, {"Citation": "Lee S., Rauch J., Kolch W. Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity. Int. J. Mol. Sci. 2020;21:1102. doi: 10.3390/ijms21031102.", "ArticleIdList": ["10.3390/ijms21031102", "PMC7037308", "32046099"]}, {"Citation": "Wojnowski L., Stancato L.F., Larner A.C., Rapp U.R., Zimmer A. Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. Mech. Dev. 2000;91:97\u2013104. doi: 10.1016/S0925-4773(99)00276-2.", "ArticleIdList": ["10.1016/S0925-4773(99)00276-2", "10704835"]}, {"Citation": "Kong T., Liu M., Ji B., Bai B., Cheng B., Wang C. Role of the Extracellular Signal-Regulated Kinase 1/2 Signaling Pathway in Ischemia-Reperfusion Injury. Front. Physiol. 2019;10:1038. doi: 10.3389/fphys.2019.01038.", "ArticleIdList": ["10.3389/fphys.2019.01038", "PMC6702336", "31474876"]}, {"Citation": "Degirmenci U., Wang M., Hu J. Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy. Cells. 2020;9:198. doi: 10.3390/cells9010198.", "ArticleIdList": ["10.3390/cells9010198", "PMC7017232", "31941155"]}, {"Citation": "Mahipal A., Kothari N., Gupta S. Epidermal growth factor receptor inhibitors: Coming of age. Cancer Control. 2014;21:74\u201379. doi: 10.1177/107327481402100111.", "ArticleIdList": ["10.1177/107327481402100111", "24357745"]}, {"Citation": "Shukla Y., Pal S.K. Dietary Cancer Chemoprevention: An Overview. Int. J. Hum. Genet. 2004;4:265\u2013276. doi: 10.1080/09723757.2004.11885905.", "ArticleIdList": ["10.1080/09723757.2004.11885905"]}, {"Citation": "Vincent T.L., Gatenby R.A. An evolutionary model for initiation, promotion, and progression in carcinogenesis. Int. J. Oncol. 2008;32:729\u2013737.", "ArticleIdList": ["18360700"]}, {"Citation": "Mohan S., Epstein J.B. Carcinogenesis and cyclooxygenase: The potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral. Oncol. 2003;39:537\u2013546. doi: 10.1016/S1368-8375(03)00035-6.", "ArticleIdList": ["10.1016/S1368-8375(03)00035-6", "12798395"]}, {"Citation": "Uray I.P., Dmitrovsky E., Brown P.H. Retinoids and rexinoids in cancer prevention: From laboratory to clinic. Semin. Oncol. 2016;43:49\u201364. doi: 10.1053/j.seminoncol.2015.09.002.", "ArticleIdList": ["10.1053/j.seminoncol.2015.09.002", "PMC4789177", "26970124"]}, {"Citation": "Brook N., Brook E., Dass C.R., Chan A., Dharmarajan A. Pigment Epithelium-Derived Factor and Sex Hormone-Responsive Cancers. Cancers. 2020;12:3483. doi: 10.3390/cancers12113483.", "ArticleIdList": ["10.3390/cancers12113483", "PMC7700359", "33238558"]}, {"Citation": "Abate-Shen C., Brown P.H., Colburn N.H., Gerner E.W., Green J.E., Lipkin M., Nelson W.G., Threadgill D. The untapped potential of genetically engineered mouse models in chemoprevention research: Opportunities and challenges. Cancer Prev. Res. 2008;1:161\u2013166. doi: 10.1158/1940-6207.CAPR-08-0076.", "ArticleIdList": ["10.1158/1940-6207.CAPR-08-0076", "PMC2758098", "19138951"]}, {"Citation": "Din F.V.N., Valanciute A., Houde V.P., Zibrova D., Green K.A., Sakamoto K., Alessi D.R., Dunlop M.G. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology. 2012;142:1504\u20131515.e3. doi: 10.1053/j.gastro.2012.02.050.", "ArticleIdList": ["10.1053/j.gastro.2012.02.050", "PMC3682211", "22406476"]}, {"Citation": "Gordaliza M. Natural products as leads to anticancer drugs. Clin. Transl. Oncol. 2007;9:767\u2013776. doi: 10.1007/s12094-007-0138-9.", "ArticleIdList": ["10.1007/s12094-007-0138-9", "18158980"]}, {"Citation": "Karikas G.A. Anticancer and chemopreventing natural products: Some biochemical and therapeutic aspects. J. BUON. 2010;15:627\u2013638.", "ArticleIdList": ["21229622"]}, {"Citation": "Newman D.J., Cragg G.M., Snader K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003;66:1022\u20131037. doi: 10.1021/np030096l.", "ArticleIdList": ["10.1021/np030096l", "12880330"]}, {"Citation": "Ma X., Wang Z. Anticancer drug discovery in the future: An evolutionary perspective. Drug Discov. Today. 2009;14:1136\u20131142. doi: 10.1016/j.drudis.2009.09.006.", "ArticleIdList": ["10.1016/j.drudis.2009.09.006", "19800414"]}, {"Citation": "Widmer N., Bardin C., Chatelut E., Paci A., Beijnen J., Lev\u00eaque D., Veal G., Astier A. Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies. Eur. J. Cancer. 2014;50:2020\u20132036. doi: 10.1016/j.ejca.2014.04.015.", "ArticleIdList": ["10.1016/j.ejca.2014.04.015", "24928190"]}, {"Citation": "Abuzenadah A.M., Al-Sayes F., Mahafujul Alam S.S., Hoque M., Karim S., Hussain I.M.R., Tabrez S. Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from Rauwolfia serpentina: Possible Implication in Cancer Therapy. Evid.-Based Complement. Altern. Med. Ecam. 2022;2022:3787162. doi: 10.1155/2022/3787162.", "ArticleIdList": ["10.1155/2022/3787162", "PMC8967534", "35368755"]}, {"Citation": "Wu X., Patterson S., Hawk E. Chemoprevention--history and general principles. Best Pract. Res. Clin. Gastroenterol. 2011;25:445\u2013459. doi: 10.1016/j.bpg.2011.10.012.", "ArticleIdList": ["10.1016/j.bpg.2011.10.012", "22122762"]}, {"Citation": "Muhammad N., Steele R., Isbell T.S., Philips N., Ray R.B. Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death. Oncotarget. 2017;8:66226\u201366236. doi: 10.18632/oncotarget.19887.", "ArticleIdList": ["10.18632/oncotarget.19887", "PMC5630406", "29029506"]}, {"Citation": "Bhattacharya S., Muhammad N., Steele R., Kornbluth J., Ray R.B. Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells. Cancer Prev. Res. 2017;10:337\u2013344. doi: 10.1158/1940-6207.CAPR-17-0046.", "ArticleIdList": ["10.1158/1940-6207.CAPR-17-0046", "PMC5499682", "28465362"]}, {"Citation": "Bhattacharya S., Muhammad N., Steele R., Peng G., Ray R.B. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth. Oncotarget. 2016;7:33202\u201333209. doi: 10.18632/oncotarget.8898.", "ArticleIdList": ["10.18632/oncotarget.8898", "PMC5078086", "27120805"]}, {"Citation": "Naz H., Tarique M., Khan P., Luqman S., Ahamad S., Islam A., Ahmad F., Hassan M.I. Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells. Mol. Cell Biochem. 2018;438:35\u201345. doi: 10.1007/s11010-017-3111-0.", "ArticleIdList": ["10.1007/s11010-017-3111-0", "28744811"]}, {"Citation": "Naz H., Tarique M., Ahamad S., Alajmi M.F., Hussain A., Rehman M.T., Luqman S., Hassan M.I. Hesperidin-CAMKIV interaction and its impact on cell proliferation and apoptosis in the human hepatic carcinoma and neuroblastoma cells. J. Cell Biochem. 2019;120:15119\u201315130. doi: 10.1002/jcb.28774.", "ArticleIdList": ["10.1002/jcb.28774", "31021496"]}, {"Citation": "Balunas M.J., Kinghorn A.D. Drug discovery from medicinal plants. Life Sci. 2005;78:431\u2013441. doi: 10.1016/j.lfs.2005.09.012.", "ArticleIdList": ["10.1016/j.lfs.2005.09.012", "16198377"]}, {"Citation": "Cragg G.M., Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005;100:72\u201379. doi: 10.1016/j.jep.2005.05.011.", "ArticleIdList": ["10.1016/j.jep.2005.05.011", "16009521"]}, {"Citation": "Burns J., Yokota T., Ashihara H., Lean M.E.J., Crozier A. Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 2002;50:3337\u20133340. doi: 10.1021/jf0112973.", "ArticleIdList": ["10.1021/jf0112973", "12010007"]}, {"Citation": "Park S.-H., Kim M., Lee S., Jung W., Kim B. Therapeutic Potential of Natural Products in Treatment of Cervical Cancer: A Review. Nutrients. 2021;13:154. doi: 10.3390/nu13010154.", "ArticleIdList": ["10.3390/nu13010154", "PMC7824868", "33466408"]}, {"Citation": "Li Y., Li S., Meng X., Gan R.-Y., Zhang J.-J., Li H.-B. Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients. 2017;9:728. doi: 10.3390/nu9070728.", "ArticleIdList": ["10.3390/nu9070728", "PMC5537842", "28698459"]}, {"Citation": "Khan N., Mukhtar H. Dietary agents for prevention and treatment of lung cancer. Cancer Lett. 2015;359:155\u2013164. doi: 10.1016/j.canlet.2015.01.038.", "ArticleIdList": ["10.1016/j.canlet.2015.01.038", "PMC4409137", "25644088"]}, {"Citation": "Man S., Luo C., Yan M., Zhao G., Ma L., Gao W. Treatment for liver cancer: From sorafenib to natural products. Eur. J. Med. Chem. 2021;224:113690. doi: 10.1016/j.ejmech.2021.113690.", "ArticleIdList": ["10.1016/j.ejmech.2021.113690", "34256124"]}, {"Citation": "Chinembiri T.N., du Plessis L.H., Gerber M., Hamman J.H., du Plessis J. Review of natural compounds for potential skin cancer treatment. Molecules. 2014;19:11679\u201311721. doi: 10.3390/molecules190811679.", "ArticleIdList": ["10.3390/molecules190811679", "PMC6271439", "25102117"]}, {"Citation": "Abuzenadah A.M., Al-Sayes F., Mahafujul Alam S.S., Hoque M., Karim S., Hussain I.M.R., Tabrez S. Elucidating Antiangiogenic Potential of Rauwolfia serpentina: VEGFR-2 Targeting-Based Molecular Docking Study. Evid. Based Complement Alternat Med. 2022;2022:6224666. doi: 10.1155/2022/6224666.", "ArticleIdList": ["10.1155/2022/6224666", "PMC8860507", "35198035"]}, {"Citation": "Rajamanickam S., Agarwal R. Natural products and colon cancer: Current status and future prospects. Drug Dev Res. 2008;69:460\u2013471. doi: 10.1002/ddr.20276.", "ArticleIdList": ["10.1002/ddr.20276", "PMC2659299", "19884979"]}, {"Citation": "Cardona-Mendoza A., Olivares-Ni\u00f1o G., D\u00edaz-B\u00e1ez D., Lafaurie G.I., Perdomo S.J. Chemopreventive and Anti-tumor Potential of Natural Products in Oral Cancer. Nutr. Cancer. 2022;74:779\u2013795. doi: 10.1080/01635581.2021.1931698.", "ArticleIdList": ["10.1080/01635581.2021.1931698", "34100309"]}, {"Citation": "Park M.N., Song H.S., Kim M., Lee M.-J., Cho W., Lee H.-J., Hwang C.-H., Kim S., Hwang Y., Kang B., et al. Review of Natural Product-Derived Compounds as Potent Antiglioblastoma Drugs. Biomed. Res. Int. 2017;2017:8139848. doi: 10.1155/2017/8139848.", "ArticleIdList": ["10.1155/2017/8139848", "PMC5664208", "29181405"]}, {"Citation": "Hwang D., Kim M., Park H., Jeong M.I., Jung W., Kim B. Natural Products and Acute Myeloid Leukemia: A Review Highlighting Mechanisms of Action. Nutrients. 2019;11:1010. doi: 10.3390/nu11051010.", "ArticleIdList": ["10.3390/nu11051010", "PMC6567155", "31058874"]}, {"Citation": "Fontana F., Raimondi M., Marzagalli M., Di Domizio A., Limonta P. Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets. Cells. 2020;9:460. doi: 10.3390/cells9020460.", "ArticleIdList": ["10.3390/cells9020460", "PMC7072821", "32085497"]}, {"Citation": "Haque I., Subramanian A., Huang C.H., Godwin A.K., Van Veldhuizen P.J., Banerjee S., Banerjee S.K. The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review. Int. J. Mol. Sci. 2017;19:107. doi: 10.3390/ijms19010107.", "ArticleIdList": ["10.3390/ijms19010107", "PMC5796057", "29301217"]}, {"Citation": "Pistollato F., Calder\u00f3n Iglesias R., Ruiz R., Aparicio S., Crespo J., Dzul Lopez L., Giampieri F., Battino M. The use of natural compounds for the targeting and chemoprevention of ovarian cancer. Cancer Lett. 2017;411:191\u2013200. doi: 10.1016/j.canlet.2017.09.050.", "ArticleIdList": ["10.1016/j.canlet.2017.09.050", "29017913"]}, {"Citation": "Cragg G.M., Grothaus P.G., Newman D.J. Impact of natural products on developing new anti-cancer agents. Chem. Rev. 2009;109:3012\u20133043. doi: 10.1021/cr900019j.", "ArticleIdList": ["10.1021/cr900019j", "19422222"]}, {"Citation": "Basmadjian C., Zhao Q., Bentouhami E., Djehal A., Nebigil C.G., Johnson R.A., Serova M., de Gramont A., Faivre S., Raymond E., et al. Cancer wars: Natural products strike back. Front. Chem. 2014;2:20. doi: 10.3389/fchem.2014.00020.", "ArticleIdList": ["10.3389/fchem.2014.00020", "PMC4013484", "24822174"]}, {"Citation": "Cragg G.M., Newman D.J. Nature: A vital source of leads for anticancer drug development. Phytochem Rev. 2009;8:313\u2013331. doi: 10.1007/s11101-009-9123-y.", "ArticleIdList": ["10.1007/s11101-009-9123-y"]}, {"Citation": "Cragg G.M., Newman D.J. Natural products: A continuing source of novel drug leads. Biochim. Biophys. Acta. 2013;1830:3670\u20133695. doi: 10.1016/j.bbagen.2013.02.008.", "ArticleIdList": ["10.1016/j.bbagen.2013.02.008", "PMC3672862", "23428572"]}, {"Citation": "Dutta S., Sadhukhan P., Saha S., Sil P.C. Regulation of Oxidative Stress by Different Naturally Occurring Polyphenolic Compounds: An Emerging Anticancer Therapeutic Approach. React. Oxyg. Species. 2017;3:81\u201395. doi: 10.20455/ros.2017.815.", "ArticleIdList": ["10.20455/ros.2017.815"]}, {"Citation": "Zamora-Ros R., B\u00e9raud V., Franceschi S., Cayssials V., Tsilidis K.K., Boutron-Ruault M.-C., Weiderpass E., Overvad K., Tj\u00f8nneland A., Eriksen A.K., et al. Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int. J. Cancer. 2018;142:449\u2013459. doi: 10.1002/ijc.30880.", "ArticleIdList": ["10.1002/ijc.30880", "PMC6198931", "28688112"]}, {"Citation": "Wang J., Jiang Y.-F. Natural compounds as anticancer agents: Experimental evidence. World J. Exp. Med. 2012;2:45\u201357. doi: 10.5493/wjem.v2.i3.45.", "ArticleIdList": ["10.5493/wjem.v2.i3.45", "PMC3905583", "24520533"]}, {"Citation": "Grothaus P.G., Cragg G.M., Newman D.J. Plant Natural Products in Anticancer Drug Discovery. Curr. Org. Chem. 2010;14:1781\u20131791. doi: 10.2174/138527210792927708.", "ArticleIdList": ["10.2174/138527210792927708"]}, {"Citation": "Tabrez S., Khan A.U., Mirza A.A., Suhail M., Jabir N.R., Zughaibi T.A., Alam M. Biosynthesis of copper oxide nanoparticles and its therapeutic efficacy against colon cancer. Nanotechnol. Rev. 2022;11:1322\u20131331. doi: 10.1515/ntrev-2022-0081.", "ArticleIdList": ["10.1515/ntrev-2022-0081"]}, {"Citation": "Iriti M., Varoni E.M. Chemopreventive Potential of Flavonoids in Oral Squamous Cell Carcinoma in Human Studies. Nutrients. 2013;5:2564\u20132576. doi: 10.3390/nu5072564.", "ArticleIdList": ["10.3390/nu5072564", "PMC3738988", "23857227"]}, {"Citation": "Shin D.M., Nannapaneni S., Patel M.R., Shi Q., Liu Y., Chen Z., Chen A.Y., El-Deiry M.W., Beitler J.J., Steuer C.E., et al. Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2020;26:5860\u20135868. doi: 10.1158/1078-0432.CCR-20-2276.", "ArticleIdList": ["10.1158/1078-0432.CCR-20-2276", "PMC8016407", "32943457"]}, {"Citation": "Cruz-Correa M., Hylind L.M., Marrero J.H., Zahurak M.L., Murray-Stewart T., Casero R.A., Montgomery E.A., Iacobuzio-Donahue C., Brosens L.A., Offerhaus G.J., et al. Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis. Gastroenterology. 2018;155:668\u2013673. doi: 10.1053/j.gastro.2018.05.031.", "ArticleIdList": ["10.1053/j.gastro.2018.05.031", "PMC6120769", "29802852"]}, {"Citation": "Luo Z., Li D., Luo X., Li L., Gu S., Yu L., Ma Y. Curcumin may serve an anticancer role in human osteosarcoma cell line U-2 OS by targeting ITPR1. Oncol. Lett. 2018;15:5593\u20135601. doi: 10.3892/ol.2018.8032.", "ArticleIdList": ["10.3892/ol.2018.8032", "PMC5840671", "29552196"]}, {"Citation": "Pastorelli D., Fabricio A.S.C., Giovanis P., D\u2019Ippolito S., Fiduccia P., Sold\u00e0 C., Buda A., Sperti C., Bardini R., Da Dalt G., et al. Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial. Pharmacol. Res. 2018;132:72\u201379. doi: 10.1016/j.phrs.2018.03.013.", "ArticleIdList": ["10.1016/j.phrs.2018.03.013", "29614381"]}, {"Citation": "Pricci M., Girardi B., Giorgio F., Losurdo G., Ierardi E., Di Leo A. Curcumin and Colorectal Cancer: From Basic to Clinical Evidences. Int. J. Mol. Sci. 2020;21:2364. doi: 10.3390/ijms21072364.", "ArticleIdList": ["10.3390/ijms21072364", "PMC7178200", "32235371"]}, {"Citation": "Williams D.E. Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3\u2019-Diindolylmethane. Front. Nutr. 2021;8:691. doi: 10.3389/fnut.2021.734334.", "ArticleIdList": ["10.3389/fnut.2021.734334", "PMC8517077", "34660663"]}, {"Citation": "Yerushalmi R., Bargil S., Ber Y., Ozlavo R., Sivan T., Rapson Y., Pomerantz A., Tsoref D., Sharon E., Caspi O., et al. 3,3-Diindolylmethane (DIM): A nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial. Carcinogenesis. 2020;41:1395\u20131401. doi: 10.1093/carcin/bgaa050.", "ArticleIdList": ["10.1093/carcin/bgaa050", "PMC7566319", "32458980"]}, {"Citation": "Hwang C., Sethi S., Heilbrun L.K., Gupta N.S., Chitale D.A., Sakr W.A., Menon M., Peabody J.O., Smith D.W., Sarkar F.H., et al. Anti-androgenic activity of absorption-enhanced 3,3\u2032-diindolylmethane in prostatectomy patients. Am. J. Transl. Res. 2016;8:166\u2013176.", "ArticleIdList": ["PMC4759426", "27069550"]}, {"Citation": "Messing E., Gee J.R., Saltzstein D.R., Kim K., diSant\u2019Agnese A., Kolesar J., Harris L., Faerber A., Havighurst T., Young J.M., et al. A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients. Cancer Prev. Res. 2012;5:621\u2013630. doi: 10.1158/1940-6207.CAPR-11-0455.", "ArticleIdList": ["10.1158/1940-6207.CAPR-11-0455", "PMC3324663", "22293631"]}, {"Citation": "Honari M., Shafabakhsh R., Reiter R.J., Mirzaei H., Asemi Z. Resveratrol is a promising agent for colorectal cancer prevention and treatment: Focus on molecular mechanisms. Cancer Cell Int. 2019;19:180. doi: 10.1186/s12935-019-0906-y.", "ArticleIdList": ["10.1186/s12935-019-0906-y", "PMC6631492", "31341423"]}, {"Citation": "Seca A.M.L., Pinto D.C.G.A. Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application. Int. J. Mol. Sci. 2018;19:263. doi: 10.3390/ijms19010263.", "ArticleIdList": ["10.3390/ijms19010263", "PMC5796209", "29337925"]}, {"Citation": "Gowd V., Ahmad A., Tarique M., Suhail M., Zughaibi T.A., Tabrez S., Khan R. Advancement of cancer immunotherapy using nanoparticles-based nanomedicine. Semin. Cancer Biol. 2022. in press .", "ArticleIdList": ["10.1016/j.semcancer.2022.03.026", "35378274"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "21"}, {"Year": "2022", "Month": "7", "Day": "8"}, {"Year": "2022", "Month": "7", "Day": "13"}, {"Year": "2022", "Month": "7", "Day": "27", "Hour": "1", "Minute": "6"}, {"Year": "2022", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["35883653", "PMC9318484", "10.3390/cells11142209", "cells11142209"]}}], "PubmedBookArticle": []}